Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study
Open Access
- 16 January 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Genetics
- Vol. 5 (1), e1000338
- https://doi.org/10.1371/journal.pgen.1000338
Abstract
Polyunsaturated fatty acids (PUFA) have a role in many physiological processes, including energy production, modulation of inflammation, and maintenance of cell membrane integrity. High plasma PUFA concentrations have been shown to have beneficial effects on cardiovascular disease and mortality. To identify genetic contributors of plasma PUFA concentrations, we conducted a genome-wide association study of plasma levels of six omega-3 and omega-6 fatty acids in 1,075 participants in the InCHIANTI study on aging. The strongest evidence for association was observed in a region of chromosome 11 that encodes three fatty acid desaturases (FADS1, FADS2, FADS3). The SNP with the most significant association was rs174537 near FADS1 in the analysis of arachidonic acid (AA; p = 5.95×10−46). Minor allele homozygotes had lower AA compared to the major allele homozygotes and rs174537 accounted for 18.6% of the additive variance in AA concentrations. This SNP was also associated with levels of eicosadienoic acid (EDA; p = 6.78×10−9) and eicosapentanoic acid (EPA; p = 1.07×10−14). Participants carrying the allele associated with higher AA, EDA, and EPA also had higher low-density lipoprotein (LDL-C) and total cholesterol levels. Outside the FADS gene cluster, the strongest region of association mapped to chromosome 6 in the region encoding an elongase of very long fatty acids 2 (ELOVL2). In this region, association was observed with EPA (rs953413; p = 1.1×10−6). The effects of rs174537 were confirmed in an independent sample of 1,076 subjects participating in the GOLDN study. The ELOVL2 SNP was associated with docosapentanoic and DHA but not with EPA in GOLDN. These findings show that polymorphisms of genes encoding enzymes in the metabolism of PUFA contribute to plasma concentrations of fatty acids. Polyunsaturated fatty acids (PUFA) have a number of beneficial effects on human health. Plasma PUFA concentrations are determined by a combination of dietary intake and metabolic efficiency. To determine the genes involved in PUFA homeostasis, we scanned the genome for genetic variations associated with plasma PUFA concentrations. The fatty acid desaturase gene, studied in previous candidate gene association studies, was the strongest determinant of plasma PUFA. A second gene encoding a fatty acid elongase was associated with long chain PUFA. The results of this study contribute to our understanding of the genetics of PUFA homeostasis. These genetic markers may be useful tools to examine the inter-relationship between diet, genetics, and disease.Keywords
This publication has 56 references indexed in Scilit:
- A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)PLoS Genetics, 2008
- Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate ResponseDiabetes Care, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humansNature Genetics, 2008
- Family-Based Association Tests for Genomewide Association ScansAmerican Journal of Human Genetics, 2007
- A genome-wide association study of global gene expressionNature Genetics, 2007
- Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthmaNature, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Heritability of Cardiovascular and Personality Traits in 6,148 SardiniansPLoS Genetics, 2006
- Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centresInternational Journal of Epidemiology, 1997